KIORA PHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
KIORA PHARMACEUTICALS, INC. (KPRX) had Stock Issued During Period, Shares, New Issues of 273 shares as of 2021-09-17, per its 10-K filed 2023-03-23.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2023-03-23
- 2021-09-17: Stock Issued During Period, Shares, New Issues 273.00 shares; Stock Issued During Period, Shares, New Issues as first filed 10.91K shares.
- 2021-08-11: Stock Issued During Period, Shares, New Issues 116.72K shares; Stock Issued During Period, Shares, New Issues as first filed 4.67M shares.
- 2021-01-06: Stock Issued During Period, Shares, New Issues 38.28K shares; Stock Issued During Period, Shares, New Issues as first filed 1.53M shares.
- 2020-01-03: Stock Issued During Period, Shares, New Issues 500.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues as first filed | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|---|
| 2021-09-17 | 273.00 shares 10-K · filed 2023-03-23 | 10.91K shares 10-K/A · filed 2022-07-07 | |
| 2021-08-11 | 116.72K shares 10-K · filed 2023-03-23 | 4.67M shares 10-Q · filed 2021-11-15 | |
| 2021-01-06 | 38.28K shares 10-K · filed 2023-03-23 | 1.53M shares 10-Q · filed 2021-05-12 | |
| 2020-01-03 | 500.00K shares 10-K/A · filed 2022-07-07 | ||
| 2019-10-02 | 600.00K shares 10-K · filed 2021-03-25 | ||
| 2018-04-17 | 2.34M shares 10-K · filed 2020-03-04 | ||
| 2017-02-21 | 642.15K shares 10-Q · filed 2017-05-05 | ||
| 2016-06-30 | 441.00K shares 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |